Related Experiment Videos
Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons
Godelieve J de Bree1, Jojanneke Heidema, Ester M M van Leeuwen
1Department of Pulmonology, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands. g.j.debree@amc.uva.nl
The Journal of Infectious Diseases
|April 20, 2005
Summary
Functional respiratory syncytial virus (RSV)-specific CD8(+) memory T cells persist in healthy individuals and COPD patients. Lower numbers in the elderly and COPD patients may increase RSV infection susceptibility.
Area of Science:
- Immunology
- Virology
- Respiratory Medicine
Background:
- Investigated respiratory syncytial virus (RSV)-specific CD8(+) memory T cell responses.
- Compared responses in healthy individuals (n=31) and chronic obstructive pulmonary disease (COPD) patients (n=9).
- Assessed frequency, memory phenotype, and proliferative needs of these T cells.
Purpose of the Study:
- To characterize RSV-specific CD8(+) memory T cell populations.
- To determine if these cells are diminished in elderly individuals and COPD patients.
- To understand the implications for susceptibility to RSV infection.
Main Methods:
- Utilized RSV tetramers to analyze RSV-specific CD8(+) T cells.
- Cultured peripheral-blood mononuclear cells with RSV peptide and cytokines to assess proliferative requirements.
- Measured expression of CD27, interleukin-7R alpha, and CCR7.
Main Results:
- RSV-specific CD8(+) memory T cells expressed high CD27 and IL-7Rα, low CCR7.
- Frequencies of RSV-specific CD8(+) T cells were lower than influenza A virus (FLU)-specific cells in healthy individuals.
- RSV-specific CD8(+) T cells were detectable only after in vitro expansion in elderly and COPD patients.
Conclusions:
- A functional pool of RSV-specific CD8(+) memory T cells exists in healthy individuals and COPD patients.
- Reduced numbers of these cells in the elderly and COPD patients may contribute to increased RSV susceptibility.
- These findings highlight potential targets for improving immune responses against RSV.